HemaSphere (Jun 2022)

P498: CLINICAL AND BIOLOGICAL MARKERS ASSOCIATED WITH LONG-TERM SURVIVAL FOR PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) IN REMISSION AFTER CHEMOTHERAPY IN THE QUAZAR AML-001 TRIAL OF ORAL AZACITIDINE

  • A. H. Wei,
  • H. Döhner,
  • H. Sayar,
  • F. Ravandi,
  • P. Montesinos,
  • H. Dombret,
  • D. Selleslag,
  • K. Porkka,
  • J.-H. Jang,
  • B. Skikne,
  • C. Beach,
  • T. Prebet,
  • G. Zhang,
  • A. Risueño,
  • M. Ugidos Guerrero,
  • W. L. See,
  • D. Menezes,
  • G. J. Roboz

DOI
https://doi.org/10.1097/01.HS9.0000844880.16190.70
Journal volume & issue
Vol. 6
pp. 397 – 398

Abstract

Read online

No abstracts available.